[go: up one dir, main page]

JPS61242589A - Production of l-sulfur-containing amino acid - Google Patents

Production of l-sulfur-containing amino acid

Info

Publication number
JPS61242589A
JPS61242589A JP60084545A JP8454585A JPS61242589A JP S61242589 A JPS61242589 A JP S61242589A JP 60084545 A JP60084545 A JP 60084545A JP 8454585 A JP8454585 A JP 8454585A JP S61242589 A JPS61242589 A JP S61242589A
Authority
JP
Japan
Prior art keywords
cysteine
serine
sulfide
tryptophan synthase
ammonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60084545A
Other languages
Japanese (ja)
Other versions
JPH0527389B2 (en
Inventor
Masao Shimada
嶋田 正雄
Takeshi Nakamura
武史 中村
Kenichi Ishiwatari
石渡 健一
Nobuyoshi Makiguchi
牧口 信義
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP60084545A priority Critical patent/JPS61242589A/en
Priority to GB08609015A priority patent/GB2174390B/en
Priority to CA000506867A priority patent/CA1299127C/en
Priority to AU56348/86A priority patent/AU562772B2/en
Priority to NL8600984A priority patent/NL8600984A/en
Priority to DE19863613388 priority patent/DE3613388A1/en
Priority to IT47912/86A priority patent/IT1190275B/en
Priority to KR1019860003103A priority patent/KR890004021B1/en
Priority to FR868605758A priority patent/FR2580667B1/en
Priority to CH1632/86A priority patent/CH666695A5/en
Publication of JPS61242589A publication Critical patent/JPS61242589A/en
Publication of JPH0527389B2 publication Critical patent/JPH0527389B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/12Methionine; Cysteine; Cystine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PURPOSE:To obtain L-cysteine and L-cystine useful as a transfusion component, cosmetic, food additive, etc., by reacting L-serine with a specific sulfide such as metal sulfide in the presence of tryptophan synthase. CONSTITUTION:The objective compound can be produced by reacting L-serine with a metal sulfide (e.g. sodium sulfide), metal hydrosulfide (e.g. sodium hydrosulfide), ammonium sulfide, ammonium hydrosulfide or ammonium polysulfide in the presence of tryptophan synthase. The tryptophan synthase can be produced by culturing a microbial strain such as Escherichia coli MT-10242 (FERM BP-20).

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、トリプトファン・シンターゼを用いてL−シ
ステインおよび/またはL−シスチンを製造する方法に
関する。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method for producing L-cysteine and/or L-cystine using tryptophan synthase.

L−システインおよびL−シスチンは輸液の成分などの
医薬用途のほか、化粧品用、食品添加剤などとして広く
使用されている。
L-cysteine and L-cystine are widely used in pharmaceutical applications such as components of infusions, as well as cosmetics, food additives, and the like.

(従来の技術) 従来、L−システインの製法としては、1)天然物から
抽出する方法、2)有機合成法、3)発酵法、4)酵素
法などが知られており、L−シスチンの製法としては、
天然物から抽出する方法またはL−システインを酸化す
る方法が知られている。これらのうちで、天然物から抽
出する方法は原料の供給が不安定であり、且つ不要な他
のアミノ酸が混入する。有機合成法は工程が複雑なうえ
にり、L分割を必要とする。更に発酵法は蓄積量が低い
(Prior art) Conventionally, known methods for producing L-cysteine include 1) extraction from natural products, 2) organic synthesis, 3) fermentation, and 4) enzymatic methods. As for the manufacturing method,
A method of extracting from natural products or a method of oxidizing L-cysteine is known. Among these methods, the method of extracting from natural products has an unstable supply of raw materials and is contaminated with other unnecessary amino acids. Organic synthesis methods involve complicated steps and require L-splitting. Furthermore, fermentation methods have low accumulation levels.

などの欠点があり工業的に有利な製法とは言い難い。酵
素を用いてL−システインを合成する方法としては、■
)システィン・シンターゼを用いてL−セリンと硫化水
素から合成する方法、2)システィン拳スルフヒドラー
ゼを用いてL−セリンと硫化水素、またはβ−クロロア
ラニンと硫化水素から合成する方法、3)システィン・
デスルフヒドラーゼを用いてβ−置換アラニンと金属硫
化物などから合成する方法、4)2−アミノ−チアゾリ
ン−4−カルボン酸から合成する方法などが知られてい
るが、工業的製法としては必ずしも有利な方法とは思わ
れない。
Due to these drawbacks, it is difficult to say that it is an industrially advantageous manufacturing method. As a method for synthesizing L-cysteine using an enzyme,
) Synthesis from L-serine and hydrogen sulfide using cysteine synthase, 2) Synthesis from L-serine and hydrogen sulfide or β-chloroalanine and hydrogen sulfide using cysteine sulfhydrase, 3) Cystine
Known methods include synthesis from β-substituted alanine and metal sulfide using desulfhydrase, and 4) synthesis from 2-amino-thiazoline-4-carboxylic acid, but these are industrial methods. It doesn't necessarily seem like an advantageous method.

(発明が解決しようとする問題点) 本発明者らは、安価なし一システィンおよび/またはL
−:ンスチンの新しい製造法に関して鋭意研究を重ねた
結果、トリプトファン・シンターゼが触媒する新たな反
応を知り、その知見に基づいて本発明を完成した。
(Problems to be Solved by the Invention) The present inventors have discovered that cysteine and/or L
-: As a result of intensive research into a new method for producing insulin, we learned of a new reaction catalyzed by tryptophan synthase, and based on this knowledge, we completed the present invention.

(問題点を解決するための手段) 本発明に用いられるトリプトファン・シンターゼを生産
する菌株としては、例えばエシェリヒア・コリMT−1
0242(FERM BP−20)、ノイロスポラ・ク
ラッナATCC14,692などがある。エシェリヒア
・コリの培養菌体からのトリプトファン・シンターゼの
抽出法については、 TheJournal ofBi
ological Chemistry 、 Vol、
252 、A1.9 。
(Means for Solving the Problems) As the strain producing tryptophan synthase used in the present invention, for example, Escherichia coli MT-1
0242 (FERM BP-20), Neurospora cranna ATCC14,692, etc. For the extraction method of tryptophan synthase from cultured cells of Escherichia coli, please refer to The Journal of Bi.
Logical Chemistry, Vol.
252, A1.9.

6594〜6599頁(1977年)、ノイロスポラ・
クラツプの培養菌体からの抽出法については、同Vol
、 250 、A8 、2941〜2946頁(197
5年)に記載され知られている。しかし1本発明に使用
されるトリプトファン・シンターゼは必ずしも抽出され
た純粋なものである必要はない。すなわち。
pp. 6594-6599 (1977), Neurospora
Regarding the extraction method from cultured bacterial cells of Clap, see Vol.
, 250, A8, pp. 2941-2946 (197
5) and is known. However, the tryptophan synthase used in the present invention does not necessarily need to be extracted and pure. Namely.

トリプトファン・シンターゼ生産菌株の培養物、培養物
から遠心分離などの方法によって採取した生菌体、その
乾燥菌体あるいは菌体を磨砕、自己消化、音波処理する
ことによって得られる菌体処理物、更にはこれもの菌体
よりの抽出物並びに該抽出物より得られる酵素の粗製物
であっても利用可能である。勿論、これらの固定化酵素
または固定化菌体でもよい。
Cultures of tryptophan synthase-producing strains, live bacterial cells collected from cultures by methods such as centrifugation, dried bacterial cells, or processed bacterial cells obtained by grinding, autolysis, or sonication of bacterial cells; Furthermore, extracts from the bacterial cells and crude enzymes obtained from the extracts can also be used. Of course, these immobilized enzymes or immobilized bacterial cells may also be used.

トリプトファン・シンターゼ生産菌を培養するための培
地としては、炭素源、窒素源、無機物および必要に応じ
て少量の微量栄養素を含むものであれば、合成培地また
は天然培地の何れも使用可能であるが1合成培地の場合
には微量のトリプトファン、アントラニル酸またはイン
ドールを培地に添加することが有効な場合もある。培地
に使用する炭素源および窒素源は使用菌の利用可能なも
のならば何れの種類を用いてもよい。すなわち、炭素源
としては、グ懇コース、グリセロール、フラクトース、
シュクロース、マルトース、マンノース、澱粉、澱粉加
水分解液、糖蜜などの種々の炭水化物が使用出来る。窒
素源としては、アンモ−ニア、塩化アンモニウム、硫酸
アンモニウム、炭酸アンモニウム、酢酸アンモニウムな
どの各種の無機および有機アンモニウム塩類、または肉
エキス、酵母エキス、コーン・スチープ・lJカー、カ
ゼイン加水分解物、フィノシーミールあるいはその消化
物、脱脂大豆粕あるいはその消化物などの天然有機窒素
源が使用可能である。
As a medium for culturing tryptophan synthase-producing bacteria, either a synthetic medium or a natural medium can be used as long as it contains a carbon source, a nitrogen source, inorganic substances, and, if necessary, small amounts of micronutrients. 1 In the case of a synthetic medium, it may be effective to add trace amounts of tryptophan, anthranilic acid or indole to the medium. As the carbon source and nitrogen source used in the culture medium, any type of carbon source and nitrogen source that can be used by the bacteria used may be used. That is, carbon sources include glucose, glycerol, fructose,
Various carbohydrates can be used, such as sucrose, maltose, mannose, starch, starch hydrolyzate, and molasses. Nitrogen sources include various inorganic and organic ammonium salts such as ammonia, ammonium chloride, ammonium sulfate, ammonium carbonate, ammonium acetate, or meat extract, yeast extract, corn steep lJ carr, casein hydrolyzate, and finocycin. Natural organic nitrogen sources such as meal or its digestate, defatted soybean meal or its digestate can be used.

天然有機窒素源の多くの場合は、窒素源であるとともに
炭素源にもなり得る。更に無機物として燐酸−水素カリ
ウム、燐酸二水素カリウム、塩化カリウム、硫酸マグネ
シウム、塩化ナトリウム、硫酸第一鉄なども必要に応じ
て使用することが出来る。
Many natural organic nitrogen sources can be both nitrogen and carbon sources. Further, as inorganic substances, potassium hydrogen phosphate, potassium dihydrogen phosphate, potassium chloride, magnesium sulfate, sodium chloride, ferrous sulfate, etc. can be used as necessary.

培養は振盪培養あるいは通気攪拌培養などの好気的条件
下で行う。培養温度は20〜50℃、通常は30〜37
°Cの範囲である。培養中の培地のpHは中性附近に維
持することが望ましい。培養期間は通常1〜3日間であ
る。
Cultivation is performed under aerobic conditions such as shaking culture or aerated agitation culture. Culture temperature is 20-50℃, usually 30-37℃
°C range. It is desirable to maintain the pH of the medium during culture near neutrality. The culture period is usually 1 to 3 days.

トリプトファン・シンターゼはインドールグリセロ燐酸
とL−セリンからL−)リプトファンを合成するβ−置
換反応のほか、α、β−説離、アミノ基転移などの反応
を触媒する多機能ピリドキサール酵素であり1本酵素の
酵素化学的性質や触媒機構はマイルズらによって詳細に
検討され、成書(例えばAdvances in En
zymology and Re1atedAreas
 of Mo1ecular Biology 、 V
ol、49 、127〜185頁(1979年))に記
載されている。しかし、トリプトファン・シンターゼに
よる本発明の反応は、本発明者らが初めて見出した反応
である。
Tryptophan synthase is a multifunctional pyridoxal enzyme that catalyzes reactions such as α, β-dissociation, and transamination in addition to the β-substitution reaction that synthesizes L-) liptophan from indole glycerophosphate and L-serine. The enzymatic chemical properties and catalytic mechanism of this enzyme were investigated in detail by Miles et al., and published in books (e.g., Advances in Enzyme).
Zymology and Re1atedAreas
of Molecular Biology, V
ol, 49, pp. 127-185 (1979)). However, the reaction of the present invention using tryptophan synthase is the first reaction discovered by the present inventors.

本発明に使用出来るセリンはL型のセリンであり、D−
セリンはトリプトファン・シンターゼの作用を受けない
ので使用出来ない。
Serine that can be used in the present invention is L-type serine, and D-
Serine cannot be used because it is not affected by tryptophan synthase.

反応液中におけるL−セリンおよび各種の硫化物の基質
濃度は特に制限はないが、通常液中濃度として0.1〜
30重量係の範囲で使用することが出来る。更に反応に
際しては、基質の他に補酵素であるピリドキサール燐酸
を微量、例えば液中濃度として0.1〜50pPの範囲
で添加するととが望ましい。また反応液中におけるトリ
プトファノシンターゼの量は、前記した様な酵素の分離
精製あるいは処理方法によって異なるが、特に制限はな
く、基質の濃度、酵素の活性、その他の条件によって適
時変更し得る。而してこの反応における反応温度は通常
20〜60°Cの範囲であり1反応p [−1は通常6
〜10の範囲である。
The substrate concentration of L-serine and various sulfides in the reaction solution is not particularly limited, but the concentration in the solution is usually from 0.1 to
It can be used within the range of 30 weight units. Further, during the reaction, it is desirable to add a trace amount of pyridoxal phosphate, which is a coenzyme, in addition to the substrate, for example, at a concentration in the solution in the range of 0.1 to 50 pP. Further, the amount of tryptophano synthase in the reaction solution varies depending on the enzyme separation and purification or processing method as described above, but is not particularly limited and can be changed as appropriate depending on the concentration of the substrate, the activity of the enzyme, and other conditions. Therefore, the reaction temperature in this reaction is usually in the range of 20 to 60°C, and 1 reaction p [-1 is usually 6
~10.

反応はバッチ法もしくは固定化酵素の場合はカラムによ
る連続法により、静置もl、 <はゆるやかな攪拌下に
行われる。反応時間は反応条件によって異なるが、バッ
チ法の場合通常5ないし72時間程度で・ある。
The reaction is carried out by a batch method or, in the case of immobilized enzymes, by a continuous method using a column, either by standing still or by gentle stirring. The reaction time varies depending on the reaction conditions, but in the case of a batch method it is usually about 5 to 72 hours.

反応液中にはL−7ステインが生成するが、L−システ
インは空気中の酸素により酸化されてL−シスチンに変
化し易いので1反応の進行とともに反応液中には通常、
L−システインとL−シスチンが共存し1時間の経過と
ともにL−シスチンの量が増大する。しかしながら1反
応条件を制御することによってI、−システインとL−
シスチンの濃度比を変えることも可能である。
L-7steine is produced in the reaction solution, but since L-cysteine is easily oxidized by oxygen in the air and converted to L-cystine, as one reaction progresses, the reaction solution usually contains
L-cysteine and L-cystine coexist, and the amount of L-cystine increases with the passage of one hour. However, by controlling the reaction conditions, I,-cysteine and L-
It is also possible to vary the concentration ratio of cystine.

反応液から■j−システインまたはL−シスチンを採取
するには通常の方法によって容易に行うことが出来る。
■J-cysteine or L-cysteine can be easily collected from the reaction solution by a conventional method.

例えば、反応終了後反応液を通気して大部分のL−シス
テインをL−シスチンに酸化すれば、L−シスチンは水
に難溶なので容易に単離できる。また、このようにして
得られたし一シスチンを電解還元すればL−システイン
を得ることが出来る。
For example, if most of L-cysteine is oxidized to L-cystine by aerating the reaction solution after the reaction is completed, L-cystine can be easily isolated since it is poorly soluble in water. Moreover, L-cysteine can be obtained by electrolytically reducing the monocystine thus obtained.

L−システインの定量は、ヨウ化メチルでS −メチル
−L−システインにした後、液体クロマトグラフィーで
行った。また、この方法でL体であることを確認した。
Quantification of L-cysteine was performed by liquid chromatography after converting it to S-methyl-L-cysteine with methyl iodide. In addition, by this method, it was confirmed that it was in the L form.

L−シスチンの定量は、ジチオスレイトールでL−シス
テインに還元した後、L−システインを定量する方法に
より行った。
Quantification of L-cysteine was performed by reducing L-cysteine with dithiothreitol and then quantifying L-cysteine.

(実施例) 以下に本発明の実施例を示す。(Example) Examples of the present invention are shown below.

実施例1 エシェリヒア・コリMT−10242(FERMBP 
−20)の培養菌体から常法に従って精製操作を行い、
比活性が9.2単位/m9(トリプトファン・シンター
ゼの1単位は、37°Cにおいて18m01/minの
トリプトファンなセリンとインドールから合成する酵素
骨)の純粋なトリプトファン・シンターゼを取得し、こ
の酵素を用いて以下の反応を行った。
Example 1 Escherichia coli MT-10242 (FERMBP
-20) from the cultured bacterial cells according to a conventional method,
We obtained pure tryptophan synthase with a specific activity of 9.2 units/m9 (one unit of tryptophan synthase is an enzyme synthesized from tryptophan serine and indole at 18 m01/min at 37°C), and The following reaction was carried out using

L−セリン50 mM 、各種の硫化物をそれぞれ別々
に1.00 mM 、ピリドキサール燐酸Q、l mM
濃度を含み、 r)r−I 8,5 (HCI )に調
節した反応液に。
L-serine 50mM, various sulfides separately 1.00mM, pyridoxal phosphate Q, lmM
Contains a concentration of r)r-I in a reaction solution adjusted to 8,5 (HCI).

トリプトファン・シンターゼの粉末を5 m9/旧にな
るように添加した。反応液10−を35℃で10時間振
盪した。生成したし一システイノおよびL−シスチンの
濃度並びに両方の和の対セリン収率を表−1に示した。
Tryptophan synthase powder was added at 5 m9/old. Reaction solution 10- was shaken at 35°C for 10 hours. Table 1 shows the concentrations of cystein and L-cysteine produced and the sum of both yields relative to serine.

  表−1 実施例2 肉エキス1係、ペプトン0.5%、酵母エキス0.1係
、燐酸二水素カリウム0.2係t’ pt−t 7,0
の液体培地50 ml / 500 ml容フラスコに
エシェリヒア・コリMT−1024−2(FER,M 
BP−20) を接種し、30℃にて20時間振盪培養
した。培養終了後、遠心分離して菌体な集め、これをト
リプトファン・シンターゼの酵素源とした。
Table-1 Example 2 Meat extract 1 part, peptone 0.5%, yeast extract 0.1 part, potassium dihydrogen phosphate 0.2 part t' pt-t 7,0
Escherichia coli MT-1024-2 (FER, M
BP-20) was inoculated and cultured with shaking at 30°C for 20 hours. After culturing, the cells were collected by centrifugation and used as an enzyme source for tryptophan synthase.

L−セリフ 200 mM 、硫化ナトリウム300 
m’M。
L-Serif 200mM, Sodium Sulfide 300mM
m'M.

ピリドキサール燐酸0.1 mM濃度を含み、 p[(
8,5(HCI)に調節した反応液に、湿菌体を50り
/lになるように添加した。反応液100m1を35°
Cで24時間振盪した。反応終了後1反応液中のL−シ
スチンをL−システインに還元してからし−システイン
の生成量を測定したところ、98 mMであり、対セリ
ン収率は49モル係であった。
Contains a 0.1 mM concentration of pyridoxal phosphate, p[(
Wet bacterial cells were added to the reaction solution adjusted to 8.5 (HCI) at a concentration of 50 l/l. 100ml of reaction solution at 35°
The mixture was shaken at C for 24 hours. After the reaction was completed, L-cysteine in one reaction solution was reduced to L-cysteine, and the amount of mustard-cysteine produced was measured to be 98 mM, and the yield relative to serine was 49 moles.

特許出願人 三井東圧化学株式会社 手  続  補  正  書 昭和60年6月lO日 特許庁長官          殿 1、事件の表示 昭和60年特許願第84545号 2、発明の名称 り一含硫アミノ酸の製造方法 6、補正をする者 事件との関係  特許出願人 住 所  東京都千代田区霞が関三丁目2番5号名 称
(312)  三井東圧化学株式会社代表者 笠 間 
祐一部 電話  593−7416 4、補正の対象 明細書の発明の詳細な説明の欄 5補正の内容 (1)明細書の第2頁第11行から第12行に亘る「シ
スティン・スルフヒドラーゼ」を[セリン・スルフヒド
ラーゼ」と訂正する。
Patent Applicant: Mitsui Toatsu Chemical Co., Ltd. Procedural Amendment Written on June 1985, Director General of the Patent Office, 1. Indication of the Case, Patent Application No. 84545, 1985. 2. Name of the Invention: Production of monosulfur-containing amino acids. Method 6, Relationship with the person making the amendment Patent applicant address 3-2-5 Kasumigaseki, Chiyoda-ku, Tokyo Name (312) Mitsui Toatsu Chemical Co., Ltd. Representative Kasama
Yuichiro Telephone: 593-7416 4. Detailed explanation of the invention column 5 of the specification subject to amendment 5 Contents of the amendment (1) "Cysteine sulfhydrase" from line 11 to line 12 of page 2 of the specification [ Serine sulfhydrase,” he corrected.

(2)明細書の第6頁第11行「L型」を1L−型1と
訂正する。
(2) "L-type" on page 6, line 11 of the specification is corrected to 1L-type 1.

(3)明細書の第8頁第10行「L体」を[L一体−1
と訂正する。
(3) Change the “L body” on page 8, line 10 of the specification to [L body-1
I am corrected.

(4)明細書の第9頁第2行1セリン」を「L−セリン
」と訂正する。
(4) "1 serine" on page 9, line 2 of the specification is corrected to "L-serine".

Claims (1)

【特許請求の範囲】[Claims] トリプトファン・シンターゼの存在下にL−セリンを、
金属硫化物、金属水硫化物、硫化アンモニウム、水硫化
アンモニウムまたは多硫化アンモニウムと反応させるこ
とを特徴とするL−システインおよび/またはL−シス
チンの製造方法。
L-serine in the presence of tryptophan synthase,
A method for producing L-cysteine and/or L-cystine, which comprises reacting with a metal sulfide, metal hydrosulfide, ammonium sulfide, ammonium hydrosulfide or ammonium polysulfide.
JP60084545A 1985-04-22 1985-04-22 Production of l-sulfur-containing amino acid Granted JPS61242589A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP60084545A JPS61242589A (en) 1985-04-22 1985-04-22 Production of l-sulfur-containing amino acid
GB08609015A GB2174390B (en) 1985-04-22 1986-04-14 Enzymatic process for preparing sulfur containing l-amino acids
CA000506867A CA1299127C (en) 1985-04-22 1986-04-16 Enzymatic process for preparing sulfur containing l-amino acids
AU56348/86A AU562772B2 (en) 1985-04-22 1986-04-17 Enzymatic process for preparing sulphur containing amino acids
NL8600984A NL8600984A (en) 1985-04-22 1986-04-18 METHOD FOR THE ENZYMATIC PREPARATION OF L-CYSTEINE AND / OR L-CYSTINE.
DE19863613388 DE3613388A1 (en) 1985-04-22 1986-04-21 ENZYMATIC METHOD FOR PRODUCING SULFURIZED L-AMINO ACIDS
IT47912/86A IT1190275B (en) 1985-04-22 1986-04-21 ENZYMATIC PROCEDURE TO PREPARE SULMIN CONTAINING SULFUR
KR1019860003103A KR890004021B1 (en) 1985-04-22 1986-04-22 Method for preparing L-cysteine, L-cystine and mixtures thereof
FR868605758A FR2580667B1 (en) 1985-04-22 1986-04-22 PROCESS FOR THE ENZYMATIC PREPARATION OF SULFUR-CONTAINING L-AMINO ACIDS
CH1632/86A CH666695A5 (en) 1985-04-22 1986-04-22 ENZYMATIC PROCESS FOR THE PREPARATION OF SULFUR-CONTAINING L-AMINO ACIDS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60084545A JPS61242589A (en) 1985-04-22 1985-04-22 Production of l-sulfur-containing amino acid

Publications (2)

Publication Number Publication Date
JPS61242589A true JPS61242589A (en) 1986-10-28
JPH0527389B2 JPH0527389B2 (en) 1993-04-21

Family

ID=13833616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60084545A Granted JPS61242589A (en) 1985-04-22 1985-04-22 Production of l-sulfur-containing amino acid

Country Status (10)

Country Link
JP (1) JPS61242589A (en)
KR (1) KR890004021B1 (en)
AU (1) AU562772B2 (en)
CA (1) CA1299127C (en)
CH (1) CH666695A5 (en)
DE (1) DE3613388A1 (en)
FR (1) FR2580667B1 (en)
GB (1) GB2174390B (en)
IT (1) IT1190275B (en)
NL (1) NL8600984A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0660157B2 (en) * 1985-11-20 1994-08-10 三井東圧化学株式会社 Method for producing cystine from cysteine
JPH0623182B2 (en) * 1986-06-19 1994-03-30 三井東圧化学株式会社 Method for separating L-cysteine hydrochloride monohydrate
CA1299128C (en) * 1986-11-19 1992-04-21 Tooru Miyahara Method of producing l-cystine
US5756319A (en) * 1995-07-18 1998-05-26 Mitsui Toatsu Chemicals, Inc. Production process of S-phenyl-L-cysteine
US6579705B2 (en) * 2001-04-04 2003-06-17 Consortium Fur Elektrochemische Industrie Gmbh Process for preparing non-proteinogenic L-amino acids
FR2854902B1 (en) * 2003-05-14 2006-06-09 Metabolic Explorer Sa MICROORGANISM WITH MODIFIED CYSTEINE SYNTHASE ACTIVITY AND PROCESS FOR PREPARING CYSTEINE
EP2348107A3 (en) 2003-02-18 2012-07-11 Metabolic Explorer Method for preparing evolved micro-organisms, enabling the creation or modification of metabolic pathways
EP1604656A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
KR101959061B1 (en) 2017-03-22 2019-03-18 대상 주식회사 Method for Preparing L-Cysteine hydrochloride

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1443280A1 (en) * 1961-05-31 1969-10-23 Von Holt Dr Med Claus Process for the preparation of 35S-L-cysteine hydrochloride
IT1012509B (en) * 1971-05-26 1977-03-10 Snam Progetti PROCEDURE FOR THE PREPARATION OF ORGANIC COMPOUNDS CONTAINING MARKED ATOMS
US3974031A (en) * 1974-05-09 1976-08-10 Mitsubishi Chemical Industries Ltd. Process for producing L-cysteine or its derivatives
JPS5838154B2 (en) * 1976-05-10 1983-08-20 三菱化学株式会社 Method for producing L-cysteines
JPS58146287A (en) * 1982-02-25 1983-08-31 Mitsui Toatsu Chem Inc Preparation of l-cysteine derivative
JPS58187198A (en) * 1982-04-27 1983-11-01 Showa Denko Kk Preparation of s-carboxymethyl-l-cysteine

Also Published As

Publication number Publication date
KR860008273A (en) 1986-11-14
CH666695A5 (en) 1988-08-15
JPH0527389B2 (en) 1993-04-21
NL8600984A (en) 1986-11-17
IT8647912A0 (en) 1986-04-21
IT1190275B (en) 1988-02-16
FR2580667B1 (en) 1989-11-03
KR890004021B1 (en) 1989-10-16
DE3613388C2 (en) 1987-07-23
GB2174390B (en) 1988-10-12
CA1299127C (en) 1992-04-21
GB8609015D0 (en) 1986-05-21
AU5634886A (en) 1986-10-30
FR2580667A1 (en) 1986-10-24
GB2174390A (en) 1986-11-05
AU562772B2 (en) 1987-06-18
DE3613388A1 (en) 1986-10-30

Similar Documents

Publication Publication Date Title
CN1200110C (en) Method of preparing non protein source L-amino acid
JPH06343462A (en) Method for producing new microorganism and l-alpha-amino acid, method for cultivating mutant and metamorphosis of new microorganism, method for obtaining gene for coding carbamoylase and/or hydantoinase and/or hydanto-inracemase and method for inserting gene for coding carbamoylase and/or hydantoinase and/or hydantoinrace-mase into microorganism or cell
JPS61242589A (en) Production of l-sulfur-containing amino acid
JP3905575B2 (en) Novel microorganism, method for producing L-α-amino acid, method for culturing mutant strain and mutant of novel microorganism, method for obtaining gene encoding carbamoylase and / or hydantoinase and / or hydantoin racemase, and carbamoylase and / or hydantoinase and / or Or insertion of a gene encoding hydantoin racemase into a microorganism or cell
JP6744997B2 (en) Escherichia microorganism producing O-phosphoserine and method for producing O-phosphoserine or L-cysteine using the same
JP2670838B2 (en) Method for producing L-α-amino acids
JP4149253B2 (en) Microbial culture method
JP2696127B2 (en) Method for producing optically active 2-hydroxycarboxylic acid
JPH02222692A (en) Production of sulfur-containing l-amino acid
JPS62143690A (en) Production of sulfur-containing l-amino acid by enzymatic process
WO2002008439A1 (en) Process for the preparation of 2-amino acids
JPH0556956B2 (en)
JPH0254077B2 (en)
JP2716477B2 (en) Method for producing S-carboxymethyl-L-cysteine
GB2075026A (en) Process for producing l-amino and oxidase
JPS62215396A (en) Production of sulfur-containing l-amino acid through fermentation process
JPS62220194A (en) Production of sulfur-containing l-amino acid
JP2004057014A (en) Method for racemizing aromatic amino acid, method for producing optically active substance of aromatic amino acid and microorganism and enzyme having racemizing activity for aromatic amino acid
JPH0272891A (en) Production of s-carboxymethyl-l-derivative
JPS6112297A (en) Production of l-phenylalanine
JPH01281094A (en) Enzymatic formation of carbon-carbon bond
JPH0254076B2 (en)
JPS6219098A (en) Separation of d-isomer from dl mixture of serine
JPH0591895A (en) Method for producing D-serine
JPS58187198A (en) Preparation of s-carboxymethyl-l-cysteine